Molecular docking for thrombolytic activity of some isolated compounds from Clausena lansium.
DOI:
https://doi.org/10.19230/jonnpr.1223Keywords:
Clausena lansium, thrombolytic activity, Molecular docking, Clausemarin BAbstract
Clausena lansium (Family- Rutaceae) is commonly known as wampee, is found in fallow lands throughout Bangladesh. Our aim of the study to performed molecular docking studies to identify potential binding affinities of the phytocompounds from Clausena lansium, namely Clausemarin B, Clausenaline C, Clausenaline E, Murrayanine, vanillic acid and Xanthotoxol for searching of lead molecule for thrombolytic activity. A wide range of docking score found during molecular docking by Schrodinger. Clausemarin B , Clausenaline C , Clausenaline E, Murrayanine , vanillic acid and Xanthotoxol showed the docking score -6.926, -4.041, -4.889 , -4.356, -3.007 and - 5.816 respectively. Among all the compounds Clausemarin B showed the best docking score. So, Clausemarin B is the best compounds for thrombolytic activity, as it possessed the best value in Molecular docking. Further in vivo investigation need to identify the thrombolytic activity of isolated compounds from Clausena lansium.
Downloads
References
Britten N. Prescribing and the defence of clinical autonomy. Sociology of Health & Illness. 2001;23(4):478-496.
McKenna CJ, Holmes DR, Schwartz RS. Novel stents for the prevention of restenosis. Trends in cardiovascular medicine. 1997;7(7):245-249.
Apu AS, Chowdhury FA, Khatun F, Jamaluddin A, Pathan AH, Pal A. Phytochemical screening and in vitro evaluation of pharmacological activities of Aphanamixis polystachya (Wall) Parker fruit extracts. Tropical Journal of Pharmaceutical Research. 2013;12(1):111-116.
Mucklow J. Thrombolytic treatment. Streptokinase is more economical than alteplase. BMJ: British Medical Journal. 1995;311(7018):1506.
Prasad S, Kashyap RS, Deopujari JY, Purohit HJ, Taori GM, Daginawala HF. Effect of Fagonia Arabica (Dhamasa) on in vitro thrombolysis. BMC Complementary and Alternative Medicine. 2007;7(1):1.
Rouf SA, Moo-Young M, Chisti Y. Tissue-type plasminogen activator: characteristics, applications and production technology. Biotechnology advances. 1996;14(3):239-266.
Hossen SM, Hoque ME, Sarkar MR, Islam MS, Hossain MS, Rashid MM. Thrombolytic & cyto-toxic property of Ethanol, Acetone & DM water extract of Tamarindus indica Linn. fruits pulp: An in-vitro evaluation. International Journal of Pharmaceutical and Life Sciences. 2012;1(2).
Sakib MH, Barman T, Karim N, Dhar R, Hossain MS, Ullah A, Al Mahmood A. IN-VITRO THROMBOLYTIC ACTIVITY OF HERBAL ANTI-ARTHEROSCLEROSIS FORMULATION. European Scientific Journal.
;11(18).
Renatus M, Bode W, Huber R, Stürzebecher J, Prasa D, Fischer S, Kohnert U, Stubbs MT. Structural Mapping of the Active Site Specificity Determinants of Human Tissue-type Plasminogen Activator IMPLICATIONS FOR THE DESIGN OF LOW MOLECULAR WEIGHT SUBSTRATES AND INHIBITORS. Journal of Biological Chemistry. 1997;272(35):21713-21719.
Venkatachalam CM, Jiang X, Oldfield T, Waldman M. LigandFit: a novel method for the shape-directed rapid docking of ligands to protein active sites. Journal of Molecular Graphics and Modelling. 2003;21(4):289-307.
Ahmed D, Kumar V, Sharma M, Verma A. Target guided isolation, in-vitro antidiabetic, antioxidant activity and molecular docking studies of some flavonoids from Albizzia Lebbeck Benth. bark. BMC complementary and alternative medicine. 2014;14(1):1.
Licciardi PV, Underwood JR. Plant-derived medicines: a novel class of immunological adjuvants. International immunopharmacology. 2011;11(3):390-398.
Liu S, Manson JE, Lee I-M, Cole SR, Hennekens CH, Willett WC, Buring JE. Fruit and vegetable intake and risk of cardiovascular disease: the Women's Health Study. The American journal of clinical nutrition. 2000;72(4):922-928.
Bazzano LA, He J, Ogden LG, Loria CM, Vupputuri S, Myers L, Whelton PK. Fruit and vegetable intake and risk of cardiovascular disease in US adults: the first National Health and Nutrition Examination Survey Epidemiologic Follow-up Study. The American journal of clinical nutrition. 2002;76(1):93-99.
Torres-Urrutia C, Guzman L, Schmeda-Hirschmann G, Moore-Carrasco R, Alarcon M, Astudillo L, Gutierrez M, Carrasco G, Yuri JA, Aranda E. Antiplatelet, anticoagulant, and fibrinolytic activity in vitro of extracts from selected fruits and vegetables. Blood Coagulation & Fibrinolysis. 2011;22(3):197-205.
Yuri JA, Neira A, Quilodran A, Motomura Y, Palomo I. Antioxidant activity and total phenolics concentration in apple peel and flesh is determined by cultivar and agroclimatic growing regions in Chile. Journal of Food, Agriculture & Environment. 2009;7(3&4):513-517.
Kowalski M, Brown G, Bieniasz M, Oszajca K, Chabielska E, Pietras T, Szemraj Z, Makandjou-Ola E, Bartkowiak J, Szemraj J. Cloning and expression of a new recombinant thrombolytic and anthithrombotic agent--A staphylokinase variant. Acta Biochimica Polonica. 2009;56(1):41.
Manach C, Mazur A, Scalbert A. Polyphenols and prevention of cardiovascular diseases. Curr Opin Lipidol. 2005;16(1):77-84
Downloads
Additional Files
Published
Issue
Section
License
All accepted originals remain the property of JONNPR. In the event of publication, the authors exclusively transfer their rights of reproduction, distribution, translation and public communication (by any sound, audiovisual or electronic medium or format) of their work. To do so, the authors shall sign a letter transferring these rights when sending the paper via the online manuscript management system.
The articles published in the journal are freely used under the terms of the Creative Commons BY NC SA license, therefore.
You are free to:
Share — copy and redistribute the material in any medium or format
Adapt — remix, transform, and build upon the material
The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
NonCommercial — You may not use the material for commercial purposes.
ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License